Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars M Wagner

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|October 13, 2007
Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature reviewLars M Wagner, Jennifer K Garrett, Edgar T Ballard, et al.
Cancer Medicine|March 14, 2018
National cancer database analysis of outcomes in pediatric glioblastomaMeng Liu, Jigisha P Thakkar, Catherine R Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Translational Pediatrics|February 7, 2024
Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trialLi-Ting Yu, Zhuo Wang, Ya-Li Han, et al.
Pediatric Blood & Cancer|December 3, 2014
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology GroupLars M Wagner, Maryam Fouladi, Atif Ahmed, et al.
Journal of Pediatric Hematology/Oncology|October 7, 2006
Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCRLars M Wagner, Rebecca A Burger, Sylvie M Guichard, et al.
Pediatric Blood & Cancer|July 12, 2011
Use of sentinel node biopsy for staging parameningeal rhabdomyosarcomaBrian D Weiss, Roshni Dasgupta, Michael J Gelfand, et al.
Pediatric Blood & Cancer|June 16, 2007
Reducing irinotecan-associated diarrhea in childrenLars M Wagner, Kristine R Crews, Clinton F Stewart, et al.
Cancer|August 27, 2016
Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trialLars M Wagner, Nathalie Kremer, Michael J Gelfand, et al.
Journal of Oncology Navigation & Survivorship|November 22, 2021
Addressing Barriers to Fertility Preservation for Cancer Patients: The Role of Oncofertility Patient NavigationCaroline S Dorfman, Juliann M Stalls, Coleman Mills, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|October 13, 2007
Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature reviewLars M Wagner, Jennifer K Garrett, Edgar T Ballard, et al.
Cancer Medicine|March 14, 2018
National cancer database analysis of outcomes in pediatric glioblastomaMeng Liu, Jigisha P Thakkar, Catherine R Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Translational Pediatrics|February 7, 2024
Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trialLi-Ting Yu, Zhuo Wang, Ya-Li Han, et al.
Pediatric Blood & Cancer|December 3, 2014
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology GroupLars M Wagner, Maryam Fouladi, Atif Ahmed, et al.
Journal of Pediatric Hematology/Oncology|October 7, 2006
Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCRLars M Wagner, Rebecca A Burger, Sylvie M Guichard, et al.
Pediatric Blood & Cancer|July 12, 2011
Use of sentinel node biopsy for staging parameningeal rhabdomyosarcomaBrian D Weiss, Roshni Dasgupta, Michael J Gelfand, et al.
Pediatric Blood & Cancer|June 16, 2007
Reducing irinotecan-associated diarrhea in childrenLars M Wagner, Kristine R Crews, Clinton F Stewart, et al.
Cancer|August 27, 2016
Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trialLars M Wagner, Nathalie Kremer, Michael J Gelfand, et al.
Journal of Oncology Navigation & Survivorship|November 22, 2021
Addressing Barriers to Fertility Preservation for Cancer Patients: The Role of Oncofertility Patient NavigationCaroline S Dorfman, Juliann M Stalls, Coleman Mills, et al.
Pageof 5